Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OcularProtect is a comprehensive dietary supplement formulated to support long-term ocular health and defend against oxidative stress. Developed by ScienceBased Health, the product contains a synergistic blend of antioxidants, including vitamins C and E, zinc, and the macular carotenoids lutein and zeaxanthin. Its primary indication is the maintenance of visual function and the protection of the retina and macula from age-related damage. The mechanism of action involves the neutralization of reactive oxygen species and the filtration of high-energy blue light, which helps to preserve the structural integrity of photoreceptor cells and the retinal pigment epithelium. The formulation is based on clinical research, including the Age-Related Eye Disease Studies (AREDS), but includes additional nutrients like alpha-lipoic acid and taurine for broader antioxidant support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OcularProtect.